Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 08:46 am Sale |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW INVESTMENTS LP | 2,637,192 6.000% |
-391,527 (-12.93%) |
Filing History |
| 2022-02-14 08:45 am Purchase |
2021-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
RTW INVESTMENTS LP | 2,058,504 7.900% |
132,910 (+6.90%) |
Filing History |
| 2022-02-14 08:44 am Sale |
2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
RTW INVESTMENTS LP | 3,806,018 6.400% |
-152,112 (-3.84%) |
Filing History |
| 2022-02-14 08:43 am Purchase |
2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW INVESTMENTS LP | 2,186,324 7.900% |
673,651 (+44.53%) |
Filing History |
| 2022-02-14 08:43 am Purchase |
2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
RTW INVESTMENTS LP | 2,520,076 6.500% |
423,233 (+20.18%) |
Filing History |
| 2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW INVESTMENTS LP | 3,921,579 8.400% |
498,724 (+14.57%) |
Filing History |
| 2022-02-14 08:41 am Sale |
2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW INVESTMENTS LP | 2,353,015 6.700% |
-409,776 (-14.83%) |
Filing History |
| 2022-02-14 08:39 am Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
RTW INVESTMENTS LP | 2,980,960 6.600% |
2,980,960 (New Position) |
Filing History |
| 2022-02-14 08:22 am Purchase |
2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW INVESTMENTS LP | 3,866,872 9.500% |
1,795,463 (+86.68%) |
Filing History |
| 2022-02-14 08:21 am Purchase |
2021-12-31 | 13G | TELA Bio, Inc. TELA |
RTW INVESTMENTS LP | 1,399,686 9.700% |
15,870 (+1.15%) |
Filing History |
| 2022-02-14 08:20 am Unchanged |
2021-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
RTW INVESTMENTS LP | 2,319,138 9.700% |
0 (Unchanged) |
Filing History |
| 2022-02-14 08:18 am Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW INVESTMENTS LP | 2,013,601 9.700% |
-450,000 (-18.27%) |
Filing History |
| 2022-02-14 08:16 am Purchase |
2021-12-31 | 13G | BrainsWay Ltd. BWAY |
RTW INVESTMENTS LP | 3,204,762 9.700% |
997,814 (+45.21%) |
Filing History |
| 2022-02-14 08:12 am Purchase |
2021-12-31 | 13G | Immunic, Inc. IMUX |
RTW INVESTMENTS LP | 1,715,470 6.500% |
1,715,470 (New Position) |
Filing History |
| 2022-02-14 08:12 am Purchase |
2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW INVESTMENTS LP | 5,810,140 9.990% |
422,627 (+7.84%) |
Filing History |
| 2022-02-14 08:10 am Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW INVESTMENTS LP | 7,027,725 9.900% |
1,939,232 (+38.11%) |
Filing History |
| 2022-02-14 08:09 am Sale |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
RTW INVESTMENTS LP | 1,906,557 5.100% |
-779,222 (-29.01%) |
Filing History |
| 2022-02-14 08:09 am Purchase |
2021-12-31 | 13G | Apyx Medical Corporation APYX |
RTW INVESTMENTS LP | 3,398,279 9.900% |
7,000 (+0.21%) |
Filing History |
| 2022-02-14 08:07 am Purchase |
2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW INVESTMENTS LP | 3,644,248 9.900% |
100,000 (+2.82%) |
Filing History |
| 2022-02-14 08:07 am Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW INVESTMENTS LP | 2,599,822 5.400% |
-1,050,247 (-28.77%) |
Filing History |